Abstract The antagonistic effects of magnesium ion as a calcium ion blocker may decrease calcium influx associated with ischemia. However, the effect of magnesium on the preischemic neonatal myocardium has not been investigated previously. The purpose of this study was to investigate the effects of the administration of increasing doses of magnesium on left ventricular performance in the neonate. We assessed left ventricular function (pressure-volume data obtained by the conductance catheter/micromanometer technique) in three groups (n=6 in each) of newborn pigs (3 to 5 days old) differing with respect to magnesium concentrations. Endsystolic elastance did not change during infusion in group A (magnesium=1.2 mmol/L), whereas in groups B (magnesium=8 mmol/L) and C (magnesium=16 mmol/L) it decreased significantly (P<.05) to 67±6% and 44±8% of baseline, respectively. The decrease in end-systolic elastance was associated with a significant reduction in cardiac output (P<.05) and stroke work (P<.05) in group C. After administration of magnesium, end-systolic elastance returned to baseline in group B in contrast to group C (78±3% of baseline value, P<.05). The slope constant of the end-diastolic pressure-volume relation decreased significantly (P<.05) from the preinfusion baseline values of 0.42±0.08 mL" 1 in group B and 0.46±0.05 mL" 1 in group C to 0.3±0.04 and 0.26±0.03 mL"', respectively, versus no change in group A. At the end of the experiment, the slope constant returned to baseline value in group B, whereas in group C it remained significantly lower (P<.05, 78±3% of baseline). We conclude that administration of 8 to 16 mmol/L magnesium affects the systolic function and alters the diastolic properties of the neonatal heart in a dose-response manner. can affect cardiac contractility and tension development by changing sarcolemmal and membrane binding of Ca 2 + , thus directly affecting resting membrane potentials and excitation-contraction coupling events.
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The effects of Mg 2 + on cardiovascular hemodynamics were studied mainly in adults. 4 -5 However, the effects of Mg 2 + on cardiac mechanics in the intact neonatal or adult heart, using the pressure-volume (PV) relation, have not been studied. Therefore, this study was designed to examine the effects of the administration of varying doses of magnesium sulfate (MgSO 4 ) on left ventricular (LV) systolic and diastolic function in the neonate.
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Methods
The effects of administration of MgSO 4 were studied in newborn pigs aged 3 to 5 days and weighing 1.6 to 2.8 kg. All animals received humane care in accordance with the guidelines of the University of Toronto Animal Care Committee. The animals were anesthetized with intravenous sodium pentobarbital (30 mg/kg) after administration of atropine sulfate (0.1 mg/kg). After endotracheal intubation, ventilation was maintained with a fixed-pressure respirator and inspired mixture of oxygen and room air (Fio 2 =0.4). A median sternotomy was performed, and the heart was suspended in a pericardial cradle. LV pressure was monitored with a high-fidelity 5F micromanometer-tipped pressure transducer (PC-350, Millar Instruments, Inc, Houston, Tex). A 5F multielectrode conductance catheter (Webster Labs, Baldwin Park, Calif) was inserted through the right carotid artery into the left ventricle with the most distal electrode placed at the apex and the most proximal electrode just cephalad to the aortic valve. Proper position of the conductance catheter was confirmed by palpation and at postmortem.
Left Ventricular Volume Measurement
The conductance catheter was connected to a model Sigma-5 signal-conditioner processor (Leycom, Oegstgeest, the Netherlands) for continuous, instantaneous LV volume measurements. 6 The use of the conductance catheter by our research group for continuous measurement of absolute LV volume in the neonatal pig was as previously described. begun at a rate of 5 mL/h (infusion pump model 921, Harvard Apparatus, Millis, Mass) and continued for 120 minutes. After stabilization for 30 minutes, serum Mg 2+ was measured and determined by atomic absorption spectroscopy, 8 and PV measurements were performed by transient inferior vena caval occlusion. The last set of PV measurements was performed 30 minutes after administration of MgSO 4 was discontinued. During the course of the experiment the hematocrit was maintained between 30% and 35%, pH between 7.35 and 7.45, and the partial oxygen and carbon dioxide tension from 150 to 250 mm Hg and from 35 to 45 mm Hg, respectively. Serial measurements of ionized Ca 2+ , K + , and glucose were performed after each serum Mg 2+ measurement. Serum ionized Ca 2+ concentration was maintained at the normal range with supplement of CaCl 2 as required. The temperature was maintained at 37°C during the experiment.
Data Analysis
The electrocardiogram (ECG) and LV pressure and volume data were recorded on Vi-in magnetic tape (PR 280, Ampex, Redwood City, Calif) and simultaneously displayed on a precalibrated digital X-Y oscilloscope (model 2090, Nicolet Instruments, Madison, Wis). The three signals were digitized by an analog-to-digital convertor (Data Translator, DT 2621) at a sample frequency of 333 Hz or every 3 milliseconds through the cardiac cycle. The obtained PV loops were analyzed including one or two steady-state beats and six to eight subsequent cycles in the first 3 seconds after inferior vena caval occlusion. End systole was defined by the points of the ratio of maximal pressure to absolute volume for each cardiac cycle. The end-systolic PV relation was generated from a leastsquares linear regression of these points with the expression P a =E M (V e ,-V 0 ) relating end-systolic pressure (P a ) to end-systolic volume (V a ), with the slope, or end-systolic elastance (E a ), and the volume axis intercept (V o ) according to the iterative technique. 9 To describe the position of the end-systolic PV relation, we calculated the volume when P a =100 mmHg (V 100 ). 10 End diastole was taken at the time corresponding to the peak of the R wave of the ECG. The end-diastolic PV relation points during caval occlusion were exponentially fitted by the equation
where P^ is end-diastolic pressure, V^ is end-diastolic volume, A and B are fitting parameters, e is the base of the natural logarithm, and k is the chamber constant, which determines the rate of change of pressure with volume." LV net stroke work was calculated as the integral of LV pressure and volume for the entire cardiac cycle. 12 The time constant of LV isovolumic relaxation (T) was computed from LV pressure data and defined as the time required for LV pressure at the time of peak -(dP/dt) to decline to one half of its value at peak -(dP/dt).
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Statistical Analysis
All data are presented as mean±SEM. A series of repeated hemodynamic variables was subjected to analysis of variance by using the SAS statistical package 14 to compare changes with baseline measurements. The level of significance was considered at a value of P<.05.
Results
The mean hemodynamic variables obtained before, during, and after administration of MgSO 4 for each group are presented in the Table. Baseline values were comparable among the groups. None of the hemodynamic variables changed in group A throughout the course of the experiment. During the infusion of MgSO 4 , LV end-systolic and end-diastolic pressures reduced significantly in groups B (i><.05) and C (P<.05). In group C, heart rate, stroke volume, stroke work, and cardiac output decreased significantly during and after administration of MgSO 4 compared with baseline (P<.05 for all variables). Fig 1 illustrates representative plots of the linear end-systolic PV relation before and during infusion of MgSO< from one animal in groups B and C. There was no change in the end-systolic PV relation in group A during and after administration of MgSO 4 , whereas in groups B and C there was a rightward and downward shift of the end-systolic PV relation, with a significant (P<.05) decrease in E a to 67±6% and 44±8% of baseline (Fig 2) . However, after MgSO 4 was discontinued, E a recovered completely in group B, in contrast to group C (78 ±4% of mean control value within a longer period of time [3 hours]). The decrease in E a was associated with a significant increase of V 10C in groups B and C (P<.05) (Fig 3) , indicating a greater LV distension. There was a downward shift of the end-systolic pressure-volume relation during infusion of MgSO 4 in both groups but to a greater extent in group C.
B, whereas in group C it remained significantly (P<.05) lower (78±3% of control value) (Fig 4) . 
After
• Before a during end-diastolic volume increased significantly (P<.05) in groups B and C during infusion of MgSO 4 . During infusion of MgSO 4 , T slowed significantly in groups B (25±1 versus 18±2 milliseconds, / > <.05) and C (27±2 versus 16±3 milliseconds, P<.05) compared with baseline; however, it returned to the control value in group B after the infusion of MgSO 4 was discontinued, and it remained significantly slower (F<.05) in group C.
Infusion of 16 mmol/L MgSO 4 resulted in a significant reduction in heart rate (Table) . Three animals were excluded from this group because of development of atrioventricular block (n=l) and sinus arrest (n=2).
Serum Calcium and Magnesium Measurements
Serum Ca 2+ level decreased significantly after administration of 16 mmol/L MgSO 4 (from 1.2+0.2 to 0.88±0.06 mmol/L, P<.05). Serum Mg 2+ concentration increased significantly only in groups B and C (from 0.8±0.1 to 1.8+0.3 mmol/L, P<.05, and from l±0.2 to 2.6±0.2 mmol/L, ,P<.05, respectively).
= 16mM
Fra 4. Bar graph shows percent change of the chamber constant (k) from baseline value during and after infusion of The total intracellular content of Mg 2+ is 17 (mmol/ L)/kg cell water for the rat ventricle; the greater part is bound to enzyme-coenzyme complexes and nucleotides. 15 The ionic activity for Mg 2+ in the heart muscle was estimated at less than 1.0 mmol/L, close to the extracellular concentration. 16 The factors that regulate Mg 2+ ionic activity remain obscure, although it has been shown that the mitochondria can accumulate and regulate cytosolic Mg 2+ by uptake and release of the cation. 17 The exchange between extracellular and intracel- concentration. 21 It also activates the Ca -ATPase of the sarcoplasmic reticulum, which, by removing Ca 2+ from the cytosol, decreases diastolic tone. 22 Magnesium sulfate has been used in the management of toxemia of pregnancy, cardiac arrhythmias, and hypertension associated with compromised renal function. It decreases blood pressure by inducing peripheral vasodilatation, an effect comparable with that of Ca 2+ antagonists. 23 However, the direct effects of Mg 2+ on cardiac mechanics in the intact animal have not been studied. The use of a conductance catheter to measure LV volume and generate a PV relation provides a precise method to separate the effects of Mg 2+ on LV function from those on the systemic vasculature.
It is also evident that Mg 2+ plays a major role in regulating the diastolic properties of the left ventricle. The decrease in the slope constant of the end-diastolic PV relation indicates a greater chamber distensibility. We speculate that this phenomenon is attributable to the competing effect of Mg 2+ with Ca 2+ on the binding sites on the actin-myosin crossbridges and the enhanced removal of Ca 2+ from the cytosol. The interaction between Mg 2+ , Ca 2+ , and myocardial function has been investigated. Shine and Douglas 24 found that the decline in tension development in isolated blood-perfused rat interventricular septa at 28°C after the administration of 0 to 20 mmol/L Mg 2+ was not dependent on Ca 2+ level in the perfusate. Similarly, in the present study, despite the maintenance of normal serum ionized Ca 2+ , the change in LV function directly correlated with the increase in Mg 2+ dose. Myocardial performance was assessed by using a multielectrode conductance catheter, providing continuous LV volume measurement. The end-systolic and diastolic PV relations, indicative of systolic and diastolic function, respectively, were obtained by reversible load alteration. The validity of this technique for assessment of cardiac contractility has been established previously in adult animals 25 and has been adapted for analysis of newborn cardiac function by our group. 7 Recently, Applegate et al 26 have shown that the conductance catheter accurately measures absolute volumes at steady state but can underestimate the slope and position of the end-systolic PV relation when it is determined by caval occlusion. However, the end-systolic PV relation accurately measures the direction and magnitude of change in LV systolic function. In addition, we have used the volume axis value at P 100 (V 100 ) as a variable describing the position of the slope of the end-systolic PV relation in the normal operating range of the left ventricle, thus avoiding the problems of interpretation of V o in a range in which curvilinearity of the slope may occur. 10 The following important changes in cardiac performance were observed in the present study during the infusion of Mg 2+ : (1) a reduction in systolic function in a dose-response manner, (2) a rightward shift in the end-diastolic PV relation caused by decreased chamber stiffness in all groups, (3) slowing of LV isovolumic relaxation, and (4) electrophysiological effects in the high-dose Mg 2+ group consisting of sinus bradycardia, decreased atrioventricular conduction, and suppression of sinus node function.
Clinical Implications
The beneficial effects of Mg 2+ as a Ca 2+ antagonist may be useful in clinical states characterized by increased chamber stiffness such as myocardial ischemia and the presence of high circulating endogenous plasma catecholamines in neonates with congenital heart defects or in potential donors for heart transplant suffering from head trauma.
